title: [The use of antistax in the treatment of discirculatory encephalopathy].
abstract: Authors have studied the effect of antistax on the cerebral venous discirculation (VD) in patients with discirculatory encephalopathy. Forty-three patients (mean age 46,8±1,8 years) received antistax in daily dose 720 mg during 2 months. Efficacy of treatment was assessed using the Visual Analogous Scale, Doppler ultrasound data, result of a non-invasive study of peripheral arterial tonus (PAT). After the completion of treatment course, the significant decrease of complaints, intensity of VD by the ultrasound data and parameters of arterial hardness by PAT data was observed. The excellent tolerability was reported by 61,1% patients; good one - by 38,9%. The results confirm the possibility of using antistax in neurological practice for treatment cerebral VD.
authors.forename: G V
authors.initials: GV
authors.lastname: Rzheusskaia
authors.forename: Iu I
authors.initials: IuI
authors.lastname: Listopadov
authors.forename: I S
authors.initials: IS
authors.lastname: Kireenkov
authors.forename: E A
authors.initials: EA
authors.lastname: Kitaeva
authors.forename: N V
authors.initials: NV
authors.lastname: Makarova
authors.forename: N A
authors.initials: NA
authors.lastname: Eremina
mesh_terms: D001921:Brain / Q000098:blood supply*; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000209:etiology; D004730:Endothelium, Vascular / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011794:Quercetin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome; D014689:Venous Insufficiency / Q000150:complications / Q000188:drug therapy*
chemical_list: C522873:Antistax; D011794:Quercetin